论文信息 - Reverse logistic process control measures for the pharmaceutical industry supply chain

Reverse logistic process control measures for the pharmaceutical industry supply chain

Purpose – The aim of this paper is to analyze the pharmaceutical supply chain using the DMAIC process for improvement of the reverse logistics in a recall to avert the possibility of harm to a consumer.Design/methodology/approach – A framework is used for guiding one towards the responsibilities of the different organizations concerning reverse logistics. This is further developed into a Cause and Effect analysis, performed on the supply chain and the hypothesized problem areas. Improvement concepts were then considered in the use of RFID, consistent information systems and transportation carriers to streamline the supply chain and reducing the risk of counterfeit drugs entering the forward supply chain. FMEA is used to understand the failure modes and the severity of the respective failures in the reverse logistics supply chain.Findings – The study yielded interesting and innovative solutions being tested and conceived at the present time, but specific information on the pharmaceutical supply chain was l...

[1] James Richardson. Beyond Partnership: Strategies for Innovation and Lean Supply , 1994 .

[2] R. Rust,et al. Return on Quality (ROQ): Making Service Quality Financially Accountable , 1995 .

[3] Peter Hines,et al. Creating world class suppliers : unlocking mutual competitive advantage , 1994 .

[4] V. Mitchell. Organizational Risk Perception and Reduction: A Literature Review , 1995 .

[5] Ronald S. Tibben-Lembke,et al. Going Backwards: Reverse Logistics Trends and Practices , 1999 .

[6] B. Burnes,et al. The benefits of reverse logistics: The case of the Manchester Royal Infirmary Pharmacy , 2000 .

[7] Yong-Ki Lee,et al. The determinants of perceived service quality and its relationship with satisfaction , 2000 .

[8] Keely L. Croxton,et al. The Supply Chain Management Processes , 2001 .

[9] Donald J. Bowersox,et al. Supply Chain Logistics Management , 2002 .

[10] Rainer Kleber,et al. Reverse logistics in a pharmaceutical company: a case study , 2003 .

[11] R. Lamming,et al. The role of risk in environment‐related supplier initiatives , 2004 .

[12] M. Droege,et al. Effectively managing pharmaceutical returns and waste , 2005 .

[13] B. Weinstein. The High Risk Scenario in the Global Economy , 2006 .

[14] K. B. Hendricks,et al. An Empirical Analysis of the Effect of Supply Chain Disruptions on Long‐Run Stock Price Performance and Equity Risk of the Firm , 2005 .